Research compounds
GLP-3 RT
Retatrutide · Synthetic Peptide Analog
In Stock
Select an option below
Dispatch from Vertex Labs
Same-day cutoff in
3:00 PM Eastern Time · In-stock items
For research use only. Not for human or veterinary use.
The compound
Description
GLP-3 RT is a synthetic Retatrutide research material, also identified in research literature as LY3437943. It is commonly classified in research contexts as a triple-receptor agonist analog. Vertex Labs supplies GLP-3 RT as a lyophilized research material in 15 mg, 20 mg, 30 mg, and 60 mg strengths for controlled laboratory research, analytical evaluation, and non-clinical research workflows.
Its defined molecular composition, Retatrutide reference identity, and triple-receptor research classification provide clear reference points for material identification, batch documentation, and controlled laboratory handling where consistency, traceability, and accurate compound verification are required.
Technical profile
Product specifications
- Reference Name
- Retatrutide
- Additional Identifier
- LY3437943
- Available Strengths
- 10 mg / 15 mg / 20 mg / 30 mg / 60 mg
- Form
- Lyophilized Powder
- Documentation
- Batch-Level COA Available
All specifications
- Compound Name
- GLP-3 RT
- Compound Class
- Synthetic Peptide Analog
- Research Classification
- Triple-Receptor Agonist Research Compound
- Molecular Formula
- C221H342N46O68
- Molecular Weight
- Approx. 4731 g/mol
- Reconstitution Status
- Not Reconstituted
- Container Type
- Sealed Vial
- Intended Use
- Laboratory Research Only
- Handling
- Qualified Personnel Only
- Storage
- Store According to Product Label
Quality & Documentation
Each GLP-3 RT batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review. Documentation may include identity confirmation, purity assessment, active weight verification, labeling review, and other analytical information relevant to the specific research batch.
Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.
Handling & Storage
GLP-3 RT should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the selected strength, product labeling, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.
Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.
Research Material Identification
GLP-3 RT is identified by its Retatrutide reference name, LY3437943 identifier, molecular formula, molecular weight, selected strength, and triple-receptor analog research classification. These characteristics provide specific reference points for distinguishing the material within controlled laboratory environments.
Researchers should verify the selected strength, vial labeling, batch number, compound identifiers, and corresponding analytical documentation before use. Maintaining accurate material identification and batch traceability supports consistent documentation across individual laboratory research workflows.
For Research Use Only. Not for human consumption. Not for veterinary use. Not intended for diagnosis, treatment, cure, or prevention of any disease.
Specifications
Additional information
| Strength | 10mg, 15mg, 20mg, 30mg, 60mg |
|---|
Batch documentation
Know your batch.
The details behind the batch
Analytical results
Select a strength to view its assigned certificate.
- Tested material
- Purity
- Measured content / potency
- Identity
- Report ID
- Appearance
- Endotoxins
- Sterility
- Heavy metals
For research use only. A certificate describes the tested sample and is not a statement of suitability for human or veterinary use.
